Lee J K, Smyth R D, Polk A, Herczeg T, Tsuei C T, Reavey-Cantwell N H
J Pharm Sci. 1977 Jun;66(6):832-4. doi: 10.1002/jps.2600660624.
A spectrophotometric method for the analysis of fenclorac and its metabolite, 3-chloro-4-cyclohexylbenzeneglycolic acid, in human serum was developed. The parent compound represented at least 90% of the total species present in blood; the metabolite was present to the extent of about 10%, primarily in the elimination phase. The basic procedure consists of extraction of both compounds from serum, further extraction to remove interfering substances, alkaline conversion of fenclorac to the alpha-hydroxy acid metabolite, oxidation of this metabolite to the corresponding benzaldehyde derivative, and spectrophotometric measurement of the absorbance of the aldehyde at 252 nm. A comparison of serum concentrations obtained by this method with concentrations calculated from 14C-data following oral administration of 1-14C-fenclorac to eight normal adult volunteers indicated a 90% correlation between methodologies over a range of 1.4-25.5 microgram of fenclorac/ml of serum.
开发了一种用于分析人血清中芬氯那酸及其代谢物3-氯-4-环己基苯乙醇酸的分光光度法。母体化合物占血液中总成分的至少90%;代谢物的含量约为10%,主要存在于消除阶段。基本步骤包括从血清中提取这两种化合物,进一步提取以去除干扰物质,将芬氯那酸碱转化为α-羟基酸代谢物,将该代谢物氧化为相应的苯甲醛衍生物,以及分光光度法测定252nm处醛的吸光度。将该方法获得的血清浓度与八名正常成年志愿者口服1-14C-芬氯那酸后根据14C数据计算出的浓度进行比较,结果表明在1.4-25.5微克芬氯那酸/毫升血清范围内,两种方法的相关性为90%。